If you need more lookups,
subscriptions start at $34 USD/month.
Markus Rohrwild Location
Switzerland
Markus Rohrwild Work
2025 -now Chief Executive Officer @
2021 -now Chairman of the Board @
2021 -now Chairman of the Board @
2024 -2025 Vice President Governance @
2021 -2024 Chief Executive Officer and Managing Director @
2020 -2022 Vice President Governance @
2018 -2019 Chief Executive Officer and Managing Director @ Emavant Solutions
2014 -2017 Global Business Franchise Head Cardio-Metabolic Medicines @
2013 -2014 Global Business Franchise Head Ophthalmics @
2011 -2013 Head Pharma and President Novartis Taiwan @
2009 -2011 Head Marketing and Sales Region AMAC (Asia-Pacific, Middle East and African Countries) @
2007 -2009 Global Brand Head Rasilez and Tekturna @
2006 -2007 Business Franchise Head Cardiovascular and Metabolism in Germany @
2005 -2006 Leadership Development Program (Sales Rotation in Germany) @
2005 -2005 Global Head New Products and Portfolio Strategy @
2003 -2005 Global Disease Area Strategy Director @
1999 -2003 Engagement Manager in Frankfurt Office, Germany @
1998 -1999 Head of Biochemistry @ Hoechst Roussel Vet GmbH (now part of MSD Animal Health)
Markus Rohrwild Education
Harvard Medical School
PhD
1994-1998
Hochschule für angewandte Wissenschaften Weihenstephan-Triesdorf
Dipl. Ing. FH
1989-1994
Markus Rohrwild Summary
Markus Rohrwild, based in Switzerland, is currently a Chief Executive Officer at Gubra. Markus Rohrwild brings experience from previous roles at Roivant, Genevant Sciences, Roivant Sciences and Affivant. Markus Rohrwild holds a 1994 - 1998 PhD @ Harvard Medical School. Markus Rohrwild has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Markus Rohrwild?
Find contact details for 700 million professionals.